Literature DB >> 20031270

Contamination of intravenous fluids: a continuing cause of hospital bacteremia.

Alejandro E Macias1, Martha Huertas, Samuel Ponce de Leon, Juan M Munoz, Alma R Chavez, Jose Sifuentes-Osornio, Carmen Romero, Miriam Bobadilla.   

Abstract

BACKGROUND: Nosocomial bacteremia caused by the contamination of intravenous (IV) infusates is considered rare. Unfortunately, this problem has been underestimated because its identification requires culturing infusates, a procedure not performed routinely.
METHODS: This study was conducted in a referral hospital where IV infusates are admixed in nursing areas. The aim was to determine the prevalence of infusate contamination in adult patients with gram-negative rod (GNR) bacteremia. Over a period of 32 months, a specimen of infusate was drawn for culture from each patient recruited after the laboratory reported a GNR in the blood.
RESULTS: A total of 384 infusates were cultured from 384 patients who had been diagnosed with GNR bacteremia. Seven infusates grew a GNR in culture, for a contamination rate of 2% (7/384; 95% confidence interval [CI] = 1% to 3%). In all cases, the infectious organism was the same as the organism isolated from the blood. Infusate contamination was responsible for 7% (7/108; 95% CI = 2% to 11%) of all primary bloodstream infections and 11% (7/62; 95% CI = 2% to 22%) of all primary bloodstream infections not associated with central venous catheter infection.
CONCLUSIONS: For patients in hospitals where IV drugs are admixed in nursing units, we recommend instituting infusate culture as routine practice following the diagnosis of a GNR in the blood. 2010 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20031270     DOI: 10.1016/j.ajic.2009.08.015

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  7 in total

1.  Pharmaceutical Quality of Selected Metronidazole and Ciprofloxacin Infusions Marketed in South Eastern Nigeria.

Authors:  Angus Nnamdi Oli; MaryRose Ukamaka Ibeabuchi; Ifeoma Bessie Enweani; Stephen Chijioke Emencheta
Journal:  Drug Healthc Patient Saf       Date:  2020-07-14

2.  Bacterial Resistance to Antibiotics and Clonal Spread in COVID-19-Positive Patients on a Tertiary Hospital Intensive Care Unit, Czech Republic.

Authors:  Lenka Doubravská; Miroslava Htoutou Sedláková; Kateřina Fišerová; Vendula Pudová; Karel Urbánek; Jana Petrželová; Magdalena Röderová; Kateřina Langová; Kristýna Mezerová; Pavla Kučová; Karel Axmann; Milan Kolář
Journal:  Antibiotics (Basel)       Date:  2022-06-08

Review 3.  A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment.

Authors:  Karin H M Larmené-Beld; Henderik W Frijlink; Katja Taxis
Journal:  Eur J Clin Pharmacol       Date:  2019-01-25       Impact factor: 2.953

Review 4.  Systematic evidence review of rates and burden of harm of intravenous admixture drug preparation errors in healthcare settings.

Authors:  Nancy Hedlund; Idal Beer; Torsten Hoppe-Tichy; Patricia Trbovich
Journal:  BMJ Open       Date:  2017-12-28       Impact factor: 2.692

5.  Personnel knowledge of intravenous admixtures: a survey in a government hospital.

Authors:  Erza Genatrika; Ika Puspitasari; Susi Ari Kristina; Teuku Nanda Saifullah Sulaiman
Journal:  Pan Afr Med J       Date:  2021-12-01

6.  Prevention of coronavirus contamination from the environment using an air-cleaning closed system drug-transfer device.

Authors:  Maya Amichay; Ortal Shimon; Eitan Raveh
Journal:  Pharm Pract (Granada)       Date:  2021-11-18

7.  Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals.

Authors:  Dora E Corzo-Leon; Tito Alvarado-Matute; Arnaldo L Colombo; Patricia Cornejo-Juarez; Jorge Cortes; Juan I Echevarria; Manuel Guzman-Blanco; Alejandro E Macias; Marcio Nucci; Luis Ostrosky-Zeichner; Alfredo Ponce-de-Leon; Flavio Queiroz-Telles; Maria E Santolaya; Luis Thompson-Moya; Iris N Tiraboschi; Jeannete Zurita; Jose Sifuentes-Osornio
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.